Available Technologies

ADDITIONAL FILTERS

296 available technologies

Research Electronic Data Capture (REDCap) Toolset

REDCap (Research Electronic Data Capture) is a secure web application for building and managing online surveys and databases. Despite its broad potential application, the primary function is for Electronic Data Capture, specifi cally for Clinical Trial Management solutions. REDCap is a globally implemented platform at over 450 institutional partners from CTSA, GCRC, RCMI and other institutions in 49 countries. The REDCap application allows users to build and manage online surveys and databases quickly and securely, and is currently in production use or development build-status for more than 44,000 projects with over 59,000 users spanning numerous research focus areas across the consortium.

Treating Glioblastoma by a Combination Therapy of Gamma-secretase inhibitors and Farnesyltransferase Inhibitors

Scientists at Vanderbilt have developed a novel therapy for gliobastoma multiform that results in minimal recurrence of the tumor. The therapy combines two inhibitors that effectively compromise tumor cell growth and survival. The therapy can be followed by radiation, a common treatment for cancer cells.

Diagnostics Management Team

The sheer volume of medical information available to physicians today is overwhelming. Diagnostic Management Team provides a concise, accurate method for ordering the correct diagnostic tests every time, and it returns the results in a uniform report format, easily read by the physician. This has already been launched within Vanderbilt University, with a high adoption rate amongst physicians and has already shown significant savings.

Stable Preparation of Fetal Hemoglobin to Improve Tissue Oxygenation

Dr. Hawiger and colleagues developed a novel form of cell-penetrating fetal hemoglobin. This technology is useful for the treatment of hemoglobinopathies or to increase oxygen delivery in any condition. The preparation is stable and sterile. Upon reconstitution, the treatment can be delivered I.V. or through transfusion.

Explore the Impact of Metabolic Dynamics in Cancer with 3-Hydroxybutyrate Cell Culture Media

D-3-Hydroxybutyrate (3-HB) cell culture medium is useful for studying cancer cells lines in a novel, but physiologically relevant, metabolic context. Cancer cells are known to have rapid glucose metaobolism and most cell-based research is carried out in glucose containing medium. Cancer cells alternatively use 3-HB as a carbon source, which is a prevalent metabolic substrate when fasting. 3-HB medium offers researchers the chance to study cell growth and chemotherapuetic agents in this novel and frequently overlooked context.

Generation of Neuroprogenitor Cells and Neurons from Human Induced Pluripotent Stem Cells by the Dorsomorphin Analog DMH1

This technology describes a novel methodology wherein human-induced pluripotent stem cells can be differentiated into neural precuror cells using DMH1 (a dorsomorphin analog). Neural progenitor cells can then be further differentiated into tyrosine hydroxylase expressing neurons.

Luciferase-expressing Embryonic Stem Cell Line for Monitoring wnt or BMP Promotor Activity

The mouse embryonic stem cell line, CGR8, has been genetically modified to express luciferase under the control of either the wnt or the BMP promoter system. This technology allows rapid visualization or genetic modification of wnt and BMP pathways in development.

Synthesis of Thallium-sensitive Fluorescent Dyes to Monitor Potassium Channel or Potassium-Dependent Transporter Activity

This technology describes a strategy for the synthesis of novel fluorescent thallium indicator dyes, which are useful for high throughput testing of potassium-dependent ion channel or transporter activity.

Antibodies to Leukocyte-Associated Immunoglobin-1 (LAIR-1)

Two rabbit anti-leukocyte-associated immunoglobin-1 (LAIR-1) polyclonal antibodies have been developed. Both intracellular (epitope 170-269) and extracellular (epitope 1-141) antibodies are available which can be used for immunoprecipitation and immunoblotting, respectively.

Antibody to Phospholipase C-gamma 2 (PLC)

Dr. Carpenter has created polyclonal anti-Phospholipase C-gamma 2 antibodies. Useful in the detection or immunoprecipitation of PLC-gamma2. This antibody is well established in the primary literature.

Subunit-Specific Antibodies to Adaptor Protein-2 (AP-2)

Dr. Carpenter's lab created antibodies which recognize either the alpha or beta subunit of Adaptor Protein-2. These antibodies are useful for researchers studying vesicle trafficking.

Human Transforming Growth Factor-Beta Type II (TGF beta) Receptor Antibody

Transforming growth factor (TGF) beta type II receptor antibodies directed towards the extracellular domain (epitope 4-19) are available from the laboratory of Harold Moses. TGF-beta-II plays an important role in several biological processes including developmental biology, cardiovascular biology and cancer.

Double Stranded RNA Specific Adenosine Deaminase (ADAR) Antisera

Emeson and colleagues have generated antisera to Double Stranded RNA Adenosine Deaminase (ADAR). ADAR has recently been shown to play critical roles in oncology and virology.

Featured Video

2012 Highlights

A motion graphic video describing operational improvements and successes of FY2012. Click here for a full PDF report.